Recent news on Oxsoralen

Valeant Pharmaceuticals Reports Fourth Quarter and Full-Year 2006 ...  -  Feb 28, 2007
American Digital Networks (press release),10% Dermatology Efudix/ Efudex(P) 32295 14307 126% 78357 60179 30% Kinerase(P) 6431 6090 6% 28937 22267 30% Oxsoralen- Ultra(P) 2814 1820 55% 10528 9364

JSJ Pharmaceuticals Assumes Sales & Marketing Responsibility of ...  -  Feb 7, 2007
PR Newswire (press release),Oxsoralen-Ultra(R) is an important product for the treatment of severe, recalcitrant, disabling psoriasis which is not adequately responsive to other forms

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional